Origin and In-Office Treatment of Retrograde Cricopharyngeus Dysfunction

咽喉反流 医学 回流 病史 家族史 疾病 内科学 儿科
作者
Marie Mailly,Robin Baudouin,Camille Thibault,Stéphane Hans,Jérôme R. Lechien
出处
期刊:JAMA otolaryngology-- head & neck surgery [American Medical Association]
卷期号:151 (4): 396-396 被引量:7
标识
DOI:10.1001/jamaoto.2024.5046
摘要

Importance Retrograde cricopharyngeus dysfunction (R-CPD) is an emerging disorder associated with disabling symptoms. The origin of R-CPD remains unknown. Objective To investigate the development of symptoms, diagnosis approach, and therapeutic outcomes of R-CPD in patients treated with in-office botulinum toxin injection (BTI) into the cricopharyngeus. Design, Setting, and Participants This was a case series including patients with R-CPD who were consecutively and prospectively recruited from April 2022 to May 2024 in an academic hospital. Semistructured interviews were conducted to collect and analyze data on each patient’s clinical history, potential causes or factors associated with R-CPD development, diagnostic approaches, and symptom presentation. Intervention Clinic-based (in-office) BTI into the cricopharyngeus. Outcomes and Measures Associations with laryngopharyngeal reflux disease, patients’ Reflux Symptom Score-12 (RSS-12), and BTI effectiveness, revisions, and complications were evaluated. Results The case series comprised 106 patients with R-CPD treated with BTI (52 females [49.1%] and 54 males [51.9%]). Their mean (SD) age at symptom onset was 13.6 (7.7) years, and at diagnosis, 30.4 (6.4) years. Sixty-eight patients (64.2%) had potential congenital R-CPD, according to the parents’ testimonies. A family history was reported in 18 of 62 cases (29.0%). In 105 cases (99.1%), patients made the diagnosis themselves despite medical consultations (n = 162), empirical treatments (n = 113), and additional examinations (n = 92). The cumulative success rate of BTI was 90.6% (96 of 106 patients). In 26 cases (24.5%), additional injections were administered to address the symptoms. Family history of R-CPD was a negative predictor of single-BTI success. Dysphagia was the primary adverse effect occurring after 89 of 126 BTIs (70.6%) and lasted a mean (SD) of 16.3 (12.0) days. In 10 cases, operating-room BTI was administered after primary in-office BTI. Conclusions and Relevance R-CPD is an emerging and poorly known disorder associated with high rates of ineffective consultations, additional examinations, and self-diagnosis by patients. In-office BTI was associated with a high rate of partial or total symptom relief and long-term effectiveness.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
echoxzy完成签到,获得积分10
刚刚
呵呵喊我完成签到 ,获得积分10
1秒前
希希完成签到 ,获得积分10
1秒前
默默完成签到 ,获得积分10
1秒前
李清完成签到 ,获得积分10
2秒前
LinniL完成签到,获得积分10
2秒前
lyx完成签到,获得积分10
3秒前
dshihb完成签到,获得积分10
4秒前
小盼完成签到,获得积分10
5秒前
可瑜完成签到,获得积分10
7秒前
fangmuyi完成签到,获得积分10
9秒前
三分之一星辰完成签到 ,获得积分10
9秒前
zys完成签到,获得积分10
10秒前
wenrui完成签到 ,获得积分10
10秒前
李木子完成签到,获得积分10
11秒前
缘分完成签到,获得积分0
11秒前
赘婿应助小盼采纳,获得10
11秒前
Fenley完成签到 ,获得积分10
11秒前
十五完成签到 ,获得积分10
12秒前
高定完成签到,获得积分10
13秒前
hua完成签到,获得积分10
14秒前
多肽药化完成签到 ,获得积分10
14秒前
海里的鱼额完成签到 ,获得积分10
15秒前
16秒前
江北小梅郎完成签到,获得积分10
17秒前
fdpb完成签到,获得积分10
18秒前
呆一起完成签到 ,获得积分10
19秒前
song_song完成签到,获得积分10
19秒前
20秒前
叮咚鸡发布了新的文献求助10
20秒前
健康的雁凡完成签到,获得积分10
21秒前
盼盼完成签到,获得积分10
21秒前
shriy完成签到,获得积分10
22秒前
Terry发布了新的文献求助10
23秒前
阿翼完成签到 ,获得积分10
23秒前
小圈圈梦魇完成签到,获得积分10
24秒前
懵懂的梦秋完成签到,获得积分10
25秒前
平淡的梦菲完成签到,获得积分10
25秒前
糖豆子完成签到,获得积分10
26秒前
大仙完成签到,获得积分10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
Adhesion Science: Principles & Practice 800
The Graphene Handbook (2019 Edition) 700
Signals, Systems, and Signal Processing 610
IEST-RP-CC018: Cleanroom Cleaning and Sanitization: Operating and Monitoring Procedures 600
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6530522
求助须知:如何正确求助?哪些是违规求助? 8323240
关于积分的说明 17818472
捐赠科研通 5631866
什么是DOI,文献DOI怎么找? 2932261
邀请新用户注册赠送积分活动 1908888
关于科研通互助平台的介绍 1768204